Dataset Information


Hypoxia Induces Production of L-2-Hydroxyglutarate.

ABSTRACT: Somatic mutations in isocitrate dehydrogenase 1 or 2 (IDH1/2) contribute to the pathogenesis of cancer via production of the "oncometabolite" D-2-hydroxyglutarate (D-2HG). Elevated D-2HG can block differentiation of malignant cells by functioning as a competitive inhibitor of ?-ketoglutarate (?-KG)-dependent enzymes, including Jumonji family histone lysine demethylases. 2HG is a chiral molecule that can exist in either the D-enantiomer or the L-enantiomer. Although cancer-associated IDH1/2 mutants produce D-2HG, biochemical studies have demonstrated that L-2HG also functions as a potent inhibitor of ?-KG-dependent enzymes. Here we report that under conditions of oxygen limitation, mammalian cells selectively produce L-2HG via enzymatic reduction of ?-KG. Hypoxia-induced L-2HG is not mediated by IDH1 or IDH2, but instead results from promiscuous substrate usage primarily by lactate dehydrogenase A (LDHA). During hypoxia, the resulting increase in L-2HG is necessary and sufficient for the induction of increased methylation of histone repressive marks, including histone 3 lysine 9 (H3K9me3).

PROVIDER: S-EPMC4527873 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4286872 | BioStudies
| S-EPMC5298178 | BioStudies
| S-EPMC5435119 | BioStudies
| S-EPMC3271133 | BioStudies
| S-EPMC5027283 | BioStudies
2013-01-01 | S-EPMC3698461 | BioStudies
| S-EPMC4197823 | BioStudies
| S-EPMC4663076 | BioStudies
| S-EPMC8246651 | BioStudies
| S-EPMC7791852 | BioStudies